Martín-Sánchez J, Angós B, Bajo CE, Rodríguez AE

Language: Spanish
References: 12
Page: 184-188
PDF size: 227.75 Kb.

Text Extraction

To the Editor:

We have read with interest the article by Javaloyes et al1 which reviews the new heart failure status (HF), depending on the left ventricular ejection fraction (LVEF): HF with mid-range ejection fraction (HFmrEF - LVEF 40-49%), where it is concluded that it is probably more of a transitional state than a nosological entity in itself.

REFERENCES

1. Javaloyes P, Marquina V, Llorens P. Insuficiencia cardíaca con fracción de eyección intermedia: ¿Nueva entidad? CorSalud [Internet]. 2018 [citado 27 Dic 2019];10(3):242-9. Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/358/732 [ Links ]

2. Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2017;19(12):1574-85. [ Links ]

3. Tromp J, Westenbrink BD, Ouwerkerk W, van Veldhuisen DJ, Samani NJ, Ponikowski P, et al. Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2018;72(10):1081-90. [ Links ]

4. Shanbhag SM, Greve AM, Aspelund T, Schelbert EB, Cao JJ, Danielsen R, et al. Prevalence and prognosis of ischaemic and non-ischaemic myocardial fibrosis in older adults. Eur Heart J. 2019 [En prensa]. DOI: https://www.doi.org/10.1093/eurheartj/ehy713 [ Links ]

5. Shioi T, Inuzuka Y. Aging as a substrate of heart failure. J Cardiol. 2012;60(6):423-8. [ Links ]

6. Streng KW, Nauta JF, Hillege HL, Anker SD, Cleland JG, Dickstein K, et al. Non-cardiac comorbidities in heart failure with reduced, mid-range and preserved ejection fraction. Int J Cardiol. 2018;271:132-9. [ Links ]

7. Llauger L, Jacob J, Corominas Lasalle G, Puig Martorell J, González Casquet P, Bullon Chia A. Disfunción renal e hiperpotasemia en la insuficiencia cardiaca aguda. Emergencias. 2018;30(5):357-8. [ Links ]

8. Kapoor JR, Kapoor R, Ju C, Heidenreich PA, Eapen ZJ, Hernandez AF, et al. Precipitating clinical factors, heart failure characterization, and outcomes in patients hospitalized with heart failure with reduced, borderline, and preserved ejection fraction. JACC Heart Fail. 2016;4(6):464-72. [ Links ]

9. Aguirre Tejedo A, Miró O. Prevalencia de factores precipitantes de insuficiencia cardiaca aguda y su impacto pronóstico: una revisión sistemática. Emergencias. 2017;29(3):185-93. [ Links ]

10. Lauritsen J, Gustafsson F, Abdulla J. Characteristics and long-term prognosis of patients with heart failure and mid-range ejection fraction compared with reduced and preserved ejection fraction: a systematic review and meta-analysis. ESC Heart Fail. 2018;5(4):685-94. [ Links ]

11. Martín-Sánchez FJ, Rodríguez-Adrada E, Vidan MT, Díez Villanueva P, Llopis García G, González Del Castillo J, et al. Impacto de las variables geriátricas en la mortalidad a 30 días de los ancianos atendidos por insuficiencia cardiaca aguda. Emergencias. 2018;30(3):149-55. [ Links ]

12. Formiga F, Chivite D. Insuficiencia cardiaca aguda: básico conocer al paciente. Emergencias. 2018;30(3):145-6. [ Links ]